Determinants of Patient Refusal of Postoperative Radiation Therapy in Sinonasal Squamous Cell Carcinoma

被引:1
|
作者
Kshirsagar, Rijul S. [1 ]
Eide, Jacob G. [1 ]
Prasad, Aman [1 ]
Carey, Ryan M. [1 ]
Rajasekaran, Karthik [1 ]
Brant, Jason A. [1 ]
Newman, Jason G. [1 ]
Palmer, James N. [1 ]
Adappa, Nithin D. [1 ]
机构
[1] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
sinonasal; squamous cell carcinoma; radiation; treatment refusal; NCDB; CANCER; SURVIVAL; HEAD;
D O I
10.1055/a-1780-4157
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives Although adjuvant radiotherapy may be indicated in patients with sinonasal squamous cell carcinoma (SNSCC) following primary surgery, some patients choose to forgo recommended postoperative radiation therapy (PORT). This study aimed to elucidate factors associated with patient refusal of recommended PORT in SNSCC and examine overall survival. Methods Retrospective analysis of patients with SNSCC treated with primary surgery from the National Cancer Database diagnosed between 2004 and 2016. A multivariable logistic regression model was created to determine the association between clinical or demographic covariates and likelihood of PORT refusal. Unadjusted Kaplan-Meier estimates, log-rank tests, and a multivariable Cox proportional hazard model were used to assess overall survival. Results A total of 2,231 patients were included in the final analysis, of which 1,456 (65.3%) were males and 73 (3.3%) refused recommended PORT. Patients older than 74 years old were more likely to refuse PORT than those younger than 54 (odds ratio [OR] 3.43, 95% confidence interval [CI]: 1.84-6.62). Median survival among the entire cohort, those who received recommended PORT, and those who refused PORT was 83.0 months (95% CI: 74.6-97.1), 83.0 months (95% CI: 74.9-98.2), and 63.6 months (95% CI: 37.3-101.4), respectively. Refusal of PORT was not associated with overall survival (hazard ratio: 0.99, 95% CI: 0.69-1.42). Conclusions PORT refusal in patients with SNSCC is rare and was found to be associated with several patient factors. The decision to forgo PORT is not independently associated with overall survival in this cohort. Further study is required to determine the clinical implications of these findings as the treatment decisions are complex.
引用
收藏
页码:232 / 239
页数:8
相关论文
共 50 条
  • [41] Impact of Postoperative Radiation Therapy Timing on Survival in HPV-Associated Oropharyngeal Squamous Cell Carcinoma
    Tian, S.
    Switchenko, J.
    Patel, M. R.
    Saba, N. F.
    Shin, D. M.
    Steuer, C.
    Dhere, V. R.
    McDonald, M. W.
    Higgins, K. A.
    Beitler, J. J.
    Curran, W. J., Jr.
    Gillespie, T.
    Stokes, W. A.
    Boyce, B. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E805 - E805
  • [42] Postoperative radiation therapy vs observation for pN1 oral cavity squamous cell carcinoma
    Suresh, Krish
    Cramer, John D.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (12): : 4136 - 4142
  • [44] Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation
    Rahmati, Rahmatullah
    Dogan, Snjezana
    Pyke, Owen
    Palmer, Frank
    Awad, Mahmoud
    Lee, Nancy
    Kraus, Dennis H.
    Shah, Jatin P.
    Patel, Snehal G.
    Ganly, Ian
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (06): : 800 - 807
  • [45] Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation
    Zhu, Yingming
    Li, Minghuan
    Kong, Li
    Yu, Jinming
    ONCOTARGETS AND THERAPY, 2016, 9 : 4187 - 4196
  • [46] Pattern of Failure after Adjuvant Radiation Therapy in Squamous Cell Carcinoma Buccal Mucosa Patient
    Hina, Mariam
    Qureshi, Bilal Mazhar
    Tariq, Maria
    Tahseen, Rabia
    Khan, Maham
    Zehra, Nawazish
    Jamil, Yumna
    Hussain, Mahak Ghulam
    Khan, Sarosh Faham
    Abrar, Sehrish
    Ali, Nasir
    Abbasi, Ahmed Nadeem
    Hafiz, Asim
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1446 - S1448
  • [47] A Clinicopathological Study of Sinonasal Squamous Cell Carcinoma and its Relation with Sinonasal Papilloma
    Pawar, S.
    Yadav, S.
    Rabade, K.
    Rane, S.
    Mittal, N.
    Bal, M.
    Patil, A.
    JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1): : S59 - S59
  • [49] Outcomes of multimodal management for sinonasal squamous cell carcinoma
    Pare, Arnaud
    Blanchard, Pierre
    Rosellini, Silvia
    Auperin, Anne
    Gorphe, Philippe
    Casiraghi, Odile
    Temam, Stephane
    Bidault, Francois
    Page, Philippe
    Kolb, Frederic
    Janot, Francois
    Plana, Antoine Moya
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2017, 45 (08) : 1124 - 1132
  • [50] Immune checkpoint inhibitors in sinonasal squamous cell carcinoma
    Park, Jong Chul
    Faquin, William C.
    Durbeck, Julia
    Faden, Daniel L.
    ORAL ONCOLOGY, 2020, 109